Suria Hamza
- SEC CIK
- 0001654495
No open-market purchases or sales filed in the past year.
Current role at each company
- ANAB Anaptysbio, IncPresident, CEOas of Feb 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Suria Hamza as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Suria HamzaPresident, CEO | SSale | −36.6K | $35.57 | −$1.30M | −34.8%68.6K after | 3 lots |
| Nov 5, 2021 (view filing) | Nov 4-5 | 1 day | Suria HamzaPresident, CEO | SSale | −20.4K | $35.00 | −$712.6K | −23.1%67.6K after | 2 lots |
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Suria HamzaPresident, CEO | SSale | −36.6K | $32.31 | −$1.18M | −35.1%67.6K after | 2 lots |
| Oct 28, 2021 (view filing) | Oct 26 | 2 days | Suria HamzaPresident, CEO | SSale | −16.0K | $30.00 | −$479.8K | −19.1%67.6K after |